Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive
compensation for actions taken through them.
The short interest data are out for the March 31 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or break them. A single failed clinical trial can mean disaster for a stock. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
The March 31 short interest data have been compared with the previous report, and short interest decreased across the board in these selected stocks.
Amgen Inc. (NASDAQ: AMGN) saw its short interest fall to 9.71 million shares from the previous level of 11.09 million. Shares closed most recently at $156.39, in a 52-week trading range of $130.09 to $181.81.
Biogen Inc. (NASDAQ: BIIB) had a short interest decrease to 2.52 million shares from the previous level of 2.88 million. Shares closed Monday at $265.19, within a 52-week range of $242.07 to $432.88.
Celgene Corp. (NASDAQ: CELG) short interest for this settlement date decreased to 9.99 million shares from the previous 12.22 million. Shares of Celgene closed most recently at $103.81, in a 52-week range of $92.98 to $140.72.
Gilead Sciences Inc. (NASDAQ: GILD) saw its short interest fall to 29.07 million shares from 31.72 million in the previous period. Shares closed Monday at $95.83, in a 52-week trading range of $81.89 to $123.37.
MannKind Corp. (NASDAQ: MNKD) saw its short interest decrease to 112.04 million shares. The previous reading was 120.54 million. Shares closed most recently at $1.52, in a 52-week trading range of $0.64 to $7.32.
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) short interest decreased to 5.38 million, compared to the previous level of 5.93 million. Shares closed most recently at $147.88, in a 52-week range of $124.16 to $208.88.
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.